Epilepsy, Temporal Lobe Clinical Trials

9 recruiting

Frequently Asked Questions

Common questions about Epilepsy, Temporal Lobe clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 19 of 9 trials

Recruiting

Investigating Epilepsy: Screening and Evaluation

EpilepsySeizuresEpilepsy, Temporal Lobe+1 more
National Institute of Neurological Disorders and Stroke (NINDS)1,000 enrolled1 locationNCT03478852
Recruiting

Surgery as a Treatment for Medically Intractable Epilepsy

EpilepsyEpilepsy, Temporal LobePartial Epilepsy
National Institute of Neurological Disorders and Stroke (NINDS)300 enrolled1 locationNCT01273129
Recruiting
Early Phase 1

Localizing Epileptic Networks Using MRI and iEEG

EpilepsyEpilepsy IntractableEpilepsy, Temporal Lobe
University of Pennsylvania290 enrolled1 locationNCT04649008
Recruiting
Phase 1Phase 2

A Phase 1/2 Study of NRTX-1001 Neuronal Cell Therapy in Drug-Resistant Bilateral Mesial Temporal Lobe Epilepsy (MTLE)

Epilepsy, Temporal Lobe
Neurona Therapeutics10 enrolled17 locationsNCT06422923
Recruiting
Not Applicable

Evaluation of the NaviFUS System in Drug Resistant Epilepsy

Drug Resistant EpilepsyEpilepsy, Temporal Lobe
Genovate-NaviFUS (Australia) Pty Ltd.18 enrolled1 locationNCT05947656
Recruiting
Not Applicable

Pre-operative Mapping of the Anterior Temporal Lobe Using Functional MRI Innovative Techniques in in Drug-resistant Epileptic Patients

Cognitive DeclineEpilepsy, Temporal Lobe
Central Hospital, Nancy, France30 enrolled1 locationNCT05339438
Recruiting
Phase 2

Enhanced MRI Imaging in Healthy Participants and Participants With Epilepsy

Epilepsy, Temporal Lobe
University of Alberta50 enrolled1 locationNCT06483061
Recruiting
Not Applicable

Pathophysiology, Psycho-emotional and Cognitive Functioning Associated With Tinnitus

TinnitusEpilepsy, Temporal Lobe
Assistance Publique - Hôpitaux de Paris300 enrolled2 locationsNCT04717388
Recruiting
Not Applicable

A Pilot Study to Evaluate the Efficacy and Safety of NaviFUS™ System Neuromodulating Treatment for Patients With Drug Resistant Epilepsy

EpilepsyDrug Resistant EpilepsyEpilepsy, Temporal Lobe
NaviFUS Corporation16 enrolled1 locationNCT06492720